IRulya Therapeutics (IRLA) Current Assets (2018 - 2026)
IRulya Therapeutics (IRLA) reported Current Assets of $123.41 million for Q2 2026, up 230.5% from $37.35 million a year earlier and up 382.5% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Current Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics posted Current Assets of $22.9 million, down 48.0% from FY2024.
- Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -30.2% (FY2020 to FY2025).
- By year, Current Assets came in at $44.04 million in FY2024 (-43.1%), $77.44 million in FY2023 (-17.4%), $93.75 million in FY2022 (-16.1%) and $111.67 million in FY2021 (-19.0%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets since Q2 2021.
- Year over year, Current Assets gained in 1 of the last eight quarters, with an average decline of 7.6%.
- The high point for year-over-year Current Assets in five years was Q2 2026 (growth of 230.5%); the low point was Q1 2025 (a decline of 52.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $25.58 million (Q1 2026), $22.9 million (Q4 2025) and $29.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 45.01 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - | 123.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 123.41 Mn |
| Mar 31, 2026 | 25.58 Mn |
| Dec 31, 2025 | 22.90 Mn |
| Sep 30, 2025 | 29.20 Mn |
| Jun 30, 2025 | 37.35 Mn |
| Mar 31, 2025 | 33.83 Mn |
| Dec 31, 2024 | 44.04 Mn |
| Sep 30, 2024 | 51.72 Mn |
| Jun 30, 2024 | 63.44 Mn |
| Mar 31, 2024 | 70.44 Mn |
| Dec 31, 2023 | 77.44 Mn |
| Sep 30, 2023 | 85.17 Mn |
| Jun 30, 2023 | 88.55 Mn |
| Mar 31, 2023 | 92.49 Mn |
| Dec 31, 2022 | 93.75 Mn |
| Sep 30, 2022 | 98.28 Mn |
| Jun 30, 2022 | 99.37 Mn |
| Mar 31, 2022 | 96.35 Mn |
| Dec 31, 2021 | 111.67 Mn |
| Sep 30, 2021 | 119.43 Mn |
API Access
IRulya Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();